A new Ca-antagonist, azelnidipine, reduced blood pressure during exercise without augmentation of sympathetic nervous system in essential hypertension : a randomized, double-blind, placebo-controlled trial

• ARITA M.

収録刊行物

• J Cardiovasc Pharmacol

  J Cardiovasc Pharmacol 33 186-192, 1999

詳細情報

• CRID: 1571698601663780096
• NII論文ID: 80010906276
• データソース種別:
  • CiNii Articles